by Caitlin Kingsley | Nov 15, 2019 | Genetic Journal
The Cystic Fibrosis (CF) community celebrates a landmark achievement this fall. For the first time, a highly effective medication is available to treat the underlying cause of CF for 90% of people with this life-threatening genetic disease. CF causes frequent lung...
by Caitlin Kingsley | Oct 30, 2017 | Genetic Journal
“The Forum on Healthcare Innovation: Technology and the Future of Healthcare Delivery” was hosted by Jackson Laboratories in Farmington, CT on the UCONN Health campus on October 25-26, 2017. The conference was full of healthcare innovators and professionals and...
